Letter to the Editor
Metformin administration attenuates dipeptidyl peptidase-4 inhibitor-induced increases in Krebs von den Lungen-6 (KL-6) levels
联用二甲双胍治疗可以缓解二肽基肽酶-4抑制剂诱导的涎液化糖链抗原-6(KL-6)水平升高
Junichi Okada,
Junichi Okada
Kan-etsu Chuo Hospital, Gunma, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author Eijiro Yamada,
Eijiro Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author Yawara Niijima,
Yawara Niijima
Kan-etsu Chuo Hospital, Gunma, Japan
Search for more papers by this author Shuichi Okada,
Corresponding Author
Shuichi Okada
Kan-etsu Chuo Hospital, Gunma, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Correspondence
Shuichi Okada, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Tel: +81 27 220 8501
Fax: +81 27 220 8136
Email: [email protected]
Search for more papers by this author Masanobu Yamada,
Masanobu Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author
Junichi Okada,
Junichi Okada
Kan-etsu Chuo Hospital, Gunma, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author Eijiro Yamada,
Eijiro Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author Yawara Niijima,
Yawara Niijima
Kan-etsu Chuo Hospital, Gunma, Japan
Search for more papers by this author Shuichi Okada,
Corresponding Author
Shuichi Okada
Kan-etsu Chuo Hospital, Gunma, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Correspondence
Shuichi Okada, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Tel: +81 27 220 8501
Fax: +81 27 220 8136
Email: [email protected]
Search for more papers by this author Masanobu Yamada,
Masanobu Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan
Search for more papers by this author
First published: 07 September 2018
No abstract is available for this article.
References
- 1Suga T, Suguyama Y, Kitamura S. Clinical study of patients with idiopathic interstitial pneumonia accompanied by diabetes mellitus [in Japanese]. Nihon Kyobu Shikkan Gakkkai Zasshi. 1994; 32: 1131-1135.
- 2Kuse N, Abe S, Kuribayashi H, et al. A case of vildagliptin-induced interstitial pneumonia. Respir Med Case Rep. 2016; 12: 10-13.
- 3Ohara N, Kaneko M, Sato K, et al. Vildagliptin-induced acute lung injury: a case report. J Med Case Rep. 2016; 10: 225.
- 4Tagaya Y, Okada S, Hisada T, Niijima Y, Yamada M. Interstitial pneumonia during administration of dipeptidyl peptidase-4 inhibitors [Letter]. J Diabetes. 2016; 8: 442.
- 5Rangarajan S, Bone NB, Zmiljewska AA, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018; 24: 1121-1127. https://doi.org/10.1038/s41591-018-0170-z.
- 6Spagnolo P, Kreuter M, Maher TM, et al. Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis. Respiration. 2018; 19: 1-9.
- 7Momo K, Takagi A, Miyaili A, Koinuma M. Assessment of statin-induced interstitial pneumonia in patients treated for hyperlipidemia using a health insurance claims database in Japan. Pulm Pharmacol Ther. 2018; 50: 88-92.
